<DOC>
	<DOCNO>NCT00977262</DOCNO>
	<brief_summary>The main objective elucidate acute effect oral intake either saturate , monounsaturated polyunsaturated fatty acid peripheral blood mononuclear cell ( PBMC ) whole genome expression obese type 2 diabetic obese subject .</brief_summary>
	<brief_title>Postprandial Inflammation Fatty Acids</brief_title>
	<detailed_description>Consumption high-fat diet lead postprandial dyslipidemia , impairment endothelial function , activation immune cell change gene expression profile immune cell peripheral blood mononuclear cell ( PBMC ) . Recently show postprandial gene expression profile PBMC plasma triglyceride ( TG ) free fatty acid ( FFA ) responses dependent type dietary fat consume ( i.e . saturate , monounsaturated polyunsaturated ) . Since obese diabetic subject usually pro-inflammatory state dyslipidemia endothelial dysfunction interested effect different fatty acid high load PBMC gene expression profile , plasma cytokine profile endothelial function subject .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>For participant : male gender 5070 yr For diabetic patient : BMI &gt; 30 kg/m2 Wellcontrolled diabetes : fasting plasma glucose concentration must &lt; 10.0 mmol/l time screen . Must sulphonylurea metformin therapy least 6 month constant dose least two month , dietary treatment least 6 months2 . For obese control : BMI &gt; 30 kg/m2 normoglycemic accord WHO criteria ( OGTT , fast blood glucose &lt; 7 mmol/L , 2 hr &lt; 7.8mmol/L ) For lean control : BMI 1825 kg/m2 normoglycemic accord WHO criteria ( OGTT , fast blood glucose &lt; 7 mmol/L , 2 hr &lt; 7.8mmol/L ) For participant : Female gender Age 50 70 year Hemoglobin level &lt; 8.4 mmol/L Allergic cow milk dairy product Allergic fish oil Vegetarian Tobacco smoker Current recent ( &lt; 4 week ) use fish oil supplement four time fish/week ; 24.35 g EPADHA fish per month ( 800 mg/day ) judge questionnaire . Received inoculation within 2 month start study plan study Donated intend donate blood 2 month study till two month study Unstable body weight ( weight gain loss &gt; 3 kg past three month ) Medical condition interfere study outcome ( i.e . cardiovascular disease , gastrointestinal disease , renal dysfunction ) Use medication know interfere glucose homeostasis ( i.e . corticosteroid ) abuse drug and/or alcohol participation another biomedical study within 1 month first screen visit For obese , type 2 diabetic subject : severe diabetes require application insulin diabetesrelated complication For obese subject lean control : hyperglycemic accord WHO criteria ( OGTT , fast blood glucose &gt; 6.0mM , 2 hr &gt; 11mM ) systolic blood pressure &gt; 160 mmHg diastolic blood pressure &gt; 100 mmHg Urinary glucose concentration ( &gt; 0.25 g/l )</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>fatty acid</keyword>
	<keyword>peripheral blood mononuclear cell</keyword>
	<keyword>inflammation</keyword>
	<keyword>nutrigenomics</keyword>
</DOC>